Previous studies performed in human breast cancer cells revealed that trisubstituted imidazole drugs targeting the oncogenic PI3K/AKT/mTOR pathway can lead to apoptosis of breast cancer cells [35]. This evidence concerns the gene AKT1 and breast carcinoma.